Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:53 PM
Ignite Modification Date:
2025-12-24 @ 4:53 PM
NCT ID:
NCT05227950
Eligibility Criteria:
Inclusion Criteria:
* Patients with histologically or cytologically confirmed initially metastatic or recurrent cancer who are expected to undergo primary palliative chemotherapy (patients who relapse after adjuvant chemotherapy before/after existing surgery can also be enrolled regardless of period)
* Patients with definitive tumor burden (Patients who do not have residual lesions due to metastasectomy are excluded. However, measurable lesions according to RECIST 1.1 are not mandatory, and evaluable lesions are possible)
* ECOG PS 0-2
* Adequate bone marrow, renal function, liver function to receive chemotherapy
* Patients with informed consent form
Exclusion Criteria:
* Patients with treating antibiotic treatment within 3 days of study enrollment due to overt or suspected infection
* Other serious illness or medical condition
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT05227950
Study Brief:
Protocol Section:
NCT05227950